Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Hydrocortisone (2.5mg) Eye Ointment
Therapeutic Category
Ophthalmology, Anti-Inflammatories
Dosage Form
Eye Ointment
Packaging Type
Tube
Packaging
15 gm
Price
₹0/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cortslide Eye Ointment contains Hydrocortisone 2.5 mg, a mild corticosteroid ophthalmic ointment used for the treatment of eye inflammation, redness, irritation, and allergic eye conditions.
It helps in reducing swelling, itching, and inflammatory reactions of the eye, providing effective relief in mild to moderate ocular inflammation.
The ointment base allows longer ocular contact, making it suitable for short-term inflammatory eye conditions under medical supervision.
Cortslide Eye Ointment is a strong addition to the ophthalmic steroid therapy segment, offering consistent prescription demand and attractive margins, making it ideal for best price PCD pharma franchise opportunities.
Common side effects may include temporary blurred vision, mild eye irritation, or burning sensation after application. Prolonged or inappropriate use may lead to increased intraocular pressure or delayed healing.
Cortslide Eye Ointment is indicated for the treatment of mild to moderate steroid-responsive inflammatory eye conditions such as allergic conjunctivitis, blepharitis, and other non-infectious ocular inflammations. Use should be under ophthalmic supervision.
Use Cortslide Eye Ointment strictly as prescribed by an ophthalmologist. Avoid long-term or unsupervised use. Do not use in viral, fungal, or untreated bacterial eye infections. Discontinue use and seek medical advice if eye pain, vision changes, or persistent irritation occurs.
Store in a cool, dry place below 25°C. Protect from direct sunlight, keep the tube tightly closed, and out of reach of children. Do not use beyond the expiry date.
Composition : Carboxymethylcellulose (1% w/v) + Oxychloro Complex (0.0075% w/v)
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Flurbiprofen (0.03% w/v) + Gatifloxacin (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Hydrocortisone 2.5mg Eye Ointment has demand in the ophthalmology and anti-inflammatory eye-care segment, making it a useful product for medical distributors, wholesalers, and pharma franchise partners focusing on eye-care and hospital ophthalmic portfolios.
Medical distributors and agencies can benefit from consistent demand in inflammatory eye conditions management under ophthalmologist supervision. Hydrocortisone is a corticosteroid that helps reduce inflammation, redness, and irritation in the eyes Commonly used in allergic conjunctivitis and other inflammatory eye conditions as prescribed by eye specialists This strengthens a reliable ophthalmic-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Hydrocortisone Eye Ointment with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from ophthalmologist prescriptions, hospital and clinic demand, steady ophthalmic usage, reliable supply chain support, and good margins in eye-care medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.